カテゴリー： GlobalInfoResearch, 世界

網膜生物製剤の世界市場2019

GlobalInfoResearchが発行した調査報告書（GIR9103520）
◆英語タイトル：Global Retinal Biologics Market 2019 by Company, Regions, Type and Application, Forecast to 2024
◆商品コード：GIR9103520
◆発行会社（リサーチ会社）：GlobalInfoResearch
◆発行日：2019年9月（※2024年版があります。お問い合わせください）
◆ページ数：123
◆レポート形式：英語 / PDF
◆納品方法：Eメール
◆調査対象地域：グローバル
◆産業分野：医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥515,040見積依頼/購入/質問フォーム
Multi User（10名様閲覧用）USD5,220 ⇒換算￥772,560見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,030,080見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalInfoResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
本調査レポートは、網膜生物製剤の世界市場について調べ、まとめました。種類別セグメントは、黄斑変性症、糖尿病網膜症、糖尿病黄斑浮腫、ブドウ膜炎、その他等、用途別セグメントは、病院、診療所、その他等に区分しました。網膜生物製剤の世界市場概観、企業動向、企業別網膜生物製剤シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。
・網膜生物製剤の市場概観
・網膜生物製剤の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等）
・網膜生物製剤の企業別販売動向、市場シェア、市場集中度、競争動向
・網膜生物製剤の世界市場規模
・網膜生物製剤の北米市場分析（アメリカ、カナダ、メキシコ等）
・網膜生物製剤のアメリカ市場規模推移
・網膜生物製剤のカナダ市場規模推移
・網膜生物製剤のメキシコ市場規模推移
・網膜生物製剤のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）
・網膜生物製剤のドイツ市場規模推移
・網膜生物製剤のイギリス市場規模推移
・網膜生物製剤のロシア市場規模推移
・網膜生物製剤のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等）
・網膜生物製剤の日本市場規模推移
・網膜生物製剤の中国市場規模推移
・網膜生物製剤の韓国市場規模推移
・網膜生物製剤のインド市場規模推移
・網膜生物製剤の東南アジア市場規模推移
・網膜生物製剤の南米市場分析（ブラジル、アルゼンチン等）
・網膜生物製剤の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等）
・網膜生物製剤の種類別分析/販売量、売上、市場シェア（黄斑変性症、糖尿病網膜症、糖尿病黄斑浮腫、ブドウ膜炎、その他）
・網膜生物製剤の用途別分析/市場規模（病院、診療所、その他）
・網膜生物製剤の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測）
・網膜生物製剤の販売チャネル・代理店・貿易業者・ディーラー分析
【レポートの概要】

Many retinal biologics have been approved by the Food and Drug Administration (FDA), the European Medicine Agency (EMA) and the China Food and Drug Administration (CFDA) for the treatment of retinal diseases. Advancements in technologies and new mechanism of action for different biologics to treat retinal diseases are anticipated to boost the retinal biologics market.

Scope of the Report:
The global Retinal Biologics market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Retinal Biologics.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Retinal Biologics market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Retinal Biologics market by product type and applications/end industries.

Market Segment by Companies, this report covers
Spark Therapeutics, Inc
F. Hoffmann-La Roche Ltd
Regeneron Pharmaceuticals, Inc
AbbVie Inc
Johnson & Johnson Services, Inc
Amgen Inc

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Macular Degeneration
Diabetic Retinopathy
Diabetic Macular Edema
Uveitis
Others

Market Segment by Applications, can be divided into
Hospitals
Clinics
Others

【レポートの目次】

Table of Contents

1 Retinal Biologics Market Overview
1.1 Product Overview and Scope of Retinal Biologics
1.2 Classification of Retinal Biologics by Types
1.2.1 Global Retinal Biologics Revenue Comparison by Types (2019-2024)
1.2.2 Global Retinal Biologics Revenue Market Share by Types in 2018
1.2.3 Macular Degeneration
1.2.4 Diabetic Retinopathy
1.2.5 Diabetic Macular Edema
1.2.6 Uveitis
1.2.7 Others
1.3 Global Retinal Biologics Market by Application
1.3.1 Global Retinal Biologics Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Retinal Biologics Market by Regions
1.4.1 Global Retinal Biologics Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Retinal Biologics Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Retinal Biologics Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Retinal Biologics Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Retinal Biologics Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Retinal Biologics Status and Prospect (2014-2024)
1.5 Global Market Size of Retinal Biologics (2014-2024)
2 Manufacturers Profiles
2.1 Spark Therapeutics, Inc
2.1.1 Business Overview
2.1.2 Retinal Biologics Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Spark Therapeutics, Inc Retinal Biologics Revenue, Gross Margin and Market Share (2017-2018)
2.2 F. Hoffmann-La Roche Ltd
2.2.1 Business Overview
2.2.2 Retinal Biologics Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 F. Hoffmann-La Roche Ltd Retinal Biologics Revenue, Gross Margin and Market Share (2017-2018)
2.3 Regeneron Pharmaceuticals, Inc
2.3.1 Business Overview
2.3.2 Retinal Biologics Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Regeneron Pharmaceuticals, Inc Retinal Biologics Revenue, Gross Margin and Market Share (2017-2018)
2.4 AbbVie Inc
2.4.1 Business Overview
2.4.2 Retinal Biologics Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 AbbVie Inc Retinal Biologics Revenue, Gross Margin and Market Share (2017-2018)
2.5 Johnson & Johnson Services, Inc
2.5.1 Business Overview
2.5.2 Retinal Biologics Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Johnson & Johnson Services, Inc Retinal Biologics Revenue, Gross Margin and Market Share (2017-2018)
2.6 Amgen Inc
2.6.1 Business Overview
2.6.2 Retinal Biologics Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Amgen Inc Retinal Biologics Revenue, Gross Margin and Market Share (2017-2018)
3 Global Retinal Biologics Market Competition, by Players
3.1 Global Retinal Biologics Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Retinal Biologics Players Market Share
3.2.2 Top 10 Retinal Biologics Players Market Share
3.3 Market Competition Trend
4 Global Retinal Biologics Market Size by Regions
4.1 Global Retinal Biologics Revenue and Market Share by Regions
4.2 North America Retinal Biologics Revenue and Growth Rate (2014-2019)
4.3 Europe Retinal Biologics Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Retinal Biologics Revenue and Growth Rate (2014-2019)
4.5 South America Retinal Biologics Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Retinal Biologics Revenue and Growth Rate (2014-2019)
5 North America Retinal Biologics Revenue by Countries
5.1 North America Retinal Biologics Revenue by Countries (2014-2019)
5.2 USA Retinal Biologics Revenue and Growth Rate (2014-2019)
5.3 Canada Retinal Biologics Revenue and Growth Rate (2014-2019)
5.4 Mexico Retinal Biologics Revenue and Growth Rate (2014-2019)
6 Europe Retinal Biologics Revenue by Countries
6.1 Europe Retinal Biologics Revenue by Countries (2014-2019)
6.2 Germany Retinal Biologics Revenue and Growth Rate (2014-2019)
6.3 UK Retinal Biologics Revenue and Growth Rate (2014-2019)
6.4 France Retinal Biologics Revenue and Growth Rate (2014-2019)
6.5 Russia Retinal Biologics Revenue and Growth Rate (2014-2019)
6.6 Italy Retinal Biologics Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Retinal Biologics Revenue by Countries
7.1 Asia-Pacific Retinal Biologics Revenue by Countries (2014-2019)
7.2 China Retinal Biologics Revenue and Growth Rate (2014-2019)
7.3 Japan Retinal Biologics Revenue and Growth Rate (2014-2019)
7.4 Korea Retinal Biologics Revenue and Growth Rate (2014-2019)
7.5 India Retinal Biologics Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Retinal Biologics Revenue and Growth Rate (2014-2019)
8 South America Retinal Biologics Revenue by Countries
8.1 South America Retinal Biologics Revenue by Countries (2014-2019)
8.2 Brazil Retinal Biologics Revenue and Growth Rate (2014-2019)
8.3 Argentina Retinal Biologics Revenue and Growth Rate (2014-2019)
8.4 Colombia Retinal Biologics Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Retinal Biologics by Countries
9.1 Middle East and Africa Retinal Biologics Revenue by Countries (2014-2019)
9.2 Saudi Arabia Retinal Biologics Revenue and Growth Rate (2014-2019)
9.3 UAE Retinal Biologics Revenue and Growth Rate (2014-2019)
9.4 Egypt Retinal Biologics Revenue and Growth Rate (2014-2019)
9.5 Nigeria Retinal Biologics Revenue and Growth Rate (2014-2019)
9.6 South Africa Retinal Biologics Revenue and Growth Rate (2014-2019)
10 Global Retinal Biologics Market Segment by Type
10.1 Global Retinal Biologics Revenue and Market Share by Type (2014-2019)
10.2 Global Retinal Biologics Market Forecast by Type (2019-2024)
10.3 Macular Degeneration Revenue Growth Rate (2014-2024)
10.4 Diabetic Retinopathy Revenue Growth Rate (2014-2024)
10.5 Diabetic Macular Edema Revenue Growth Rate (2014-2024)
10.6 Uveitis Revenue Growth Rate (2014-2024)
10.7 Others Revenue Growth Rate (2014-2024)
11 Global Retinal Biologics Market Segment by Application
11.1 Global Retinal Biologics Revenue Market Share by Application (2014-2019)
11.2 Retinal Biologics Market Forecast by Application (2019-2024)
11.3 Hospitals Revenue Growth (2014-2019)
11.4 Clinics Revenue Growth (2014-2019)
11.5 Others Revenue Growth (2014-2019)
12 Global Retinal Biologics Market Size Forecast (2019-2024)
12.1 Global Retinal Biologics Market Size Forecast (2019-2024)
12.2 Global Retinal Biologics Market Forecast by Regions (2019-2024)
12.3 North America Retinal Biologics Revenue Market Forecast (2019-2024)
12.4 Europe Retinal Biologics Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Retinal Biologics Revenue Market Forecast (2019-2024)
12.6 South America Retinal Biologics Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Retinal Biologics Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source

List of Tables and Figures

Figure Retinal Biologics Picture
Table Product Specifications of Retinal Biologics
Table Global Retinal Biologics and Revenue (Million USD) Market Split by Product Type
Figure Global Retinal Biologics Revenue Market Share by Types in 2018
Figure Macular Degeneration Picture
Figure Diabetic Retinopathy Picture
Figure Diabetic Macular Edema Picture
Figure Uveitis Picture
Figure Others Picture
Table Global Retinal Biologics Revenue (Million USD) by Application (2014-2024)
Figure Retinal Biologics Revenue Market Share by Applications in 2018
Figure Hospitals Picture
Figure Clinics Picture
Figure Others Picture
Table Global Market Retinal Biologics Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Retinal Biologics Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Retinal Biologics Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Retinal Biologics Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Retinal Biologics Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Retinal Biologics Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Retinal Biologics Revenue (Million USD) and Growth Rate (2014-2024)
Table Spark Therapeutics, Inc Basic Information, Manufacturing Base and Competitors
Table Spark Therapeutics, Inc Retinal Biologics Type and Applications
Table Spark Therapeutics, Inc Retinal Biologics Revenue, Gross Margin and Market Share (2017-2018)
Table F. Hoffmann-La Roche Ltd Basic Information, Manufacturing Base and Competitors
Table F. Hoffmann-La Roche Ltd Retinal Biologics Type and Applications
Table F. Hoffmann-La Roche Ltd Retinal Biologics Revenue, Gross Margin and Market Share (2017-2018)
Table Regeneron Pharmaceuticals, Inc Basic Information, Manufacturing Base and Competitors
Table Regeneron Pharmaceuticals, Inc Retinal Biologics Type and Applications
Table Regeneron Pharmaceuticals, Inc Retinal Biologics Revenue, Gross Margin and Market Share (2017-2018)
Table AbbVie Inc Basic Information, Manufacturing Base and Competitors
Table AbbVie Inc Retinal Biologics Type and Applications
Table AbbVie Inc Retinal Biologics Revenue, Gross Margin and Market Share (2017-2018)
Table Johnson & Johnson Services, Inc Basic Information, Manufacturing Base and Competitors
Table Johnson & Johnson Services, Inc Retinal Biologics Type and Applications
Table Johnson & Johnson Services, Inc Retinal Biologics Revenue, Gross Margin and Market Share (2017-2018)
Table Amgen Inc Basic Information, Manufacturing Base and Competitors
Table Amgen Inc Retinal Biologics Type and Applications
Table Amgen Inc Retinal Biologics Revenue, Gross Margin and Market Share (2017-2018)
Table Global Retinal Biologics Revenue (Million USD) by Players (2014-2019)
Table Global Retinal Biologics Revenue Share by Players (2014-2019)
Figure Global Retinal Biologics Revenue Share by Players in 2017
Figure Global Retinal Biologics Revenue Share by Players in 2018
Figure Global Top 5 Players Retinal Biologics Revenue Market Share in 2018
Figure Global Top 10 Players Retinal Biologics Revenue Market Share in 2018
Figure Global Retinal Biologics Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Retinal Biologics Revenue (Million USD) by Regions (2014-2019)
Table Global Retinal Biologics Revenue Market Share by Regions (2014-2019)
Figure Global Retinal Biologics Revenue Market Share by Regions (2014-2019)
Figure Global Retinal Biologics Revenue Market Share by Regions in 2018
Figure North America Retinal Biologics Revenue and Growth Rate (2014-2019)
Figure Europe Retinal Biologics Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Retinal Biologics Revenue and Growth Rate (2014-2019)
Figure South America Retinal Biologics Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Retinal Biologics Revenue and Growth Rate (2014-2019)
Table North America Retinal Biologics Revenue by Countries (2014-2019)
Table North America Retinal Biologics Revenue Market Share by Countries (2014-2019)
Figure North America Retinal Biologics Revenue Market Share by Countries (2014-2019)
Figure North America Retinal Biologics Revenue Market Share by Countries in 2018
Figure USA Retinal Biologics Revenue and Growth Rate (2014-2019)
Figure Canada Retinal Biologics Revenue and Growth Rate (2014-2019)
Figure Mexico Retinal Biologics Revenue and Growth Rate (2014-2019)
Table Europe Retinal Biologics Revenue (Million USD) by Countries (2014-2019)
Figure Europe Retinal Biologics Revenue Market Share by Countries (2014-2019)
Figure Europe Retinal Biologics Revenue Market Share by Countries in 2018
Figure Germany Retinal Biologics Revenue and Growth Rate (2014-2019)
Figure UK Retinal Biologics Revenue and Growth Rate (2014-2019)
Figure France Retinal Biologics Revenue and Growth Rate (2014-2019)
Figure Russia Retinal Biologics Revenue and Growth Rate (2014-2019)
Figure Italy Retinal Biologics Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Retinal Biologics Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Retinal Biologics Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Retinal Biologics Revenue Market Share by Countries in 2018
Figure China Retinal Biologics Revenue and Growth Rate (2014-2019)
Figure Japan Retinal Biologics Revenue and Growth Rate (2014-2019)
Figure Korea Retinal Biologics Revenue and Growth Rate (2014-2019)
Figure India Retinal Biologics Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Retinal Biologics Revenue and Growth Rate (2014-2019)
Table South America Retinal Biologics Revenue by Countries (2014-2019)
Table South America Retinal Biologics Revenue Market Share by Countries (2014-2019)
Figure South America Retinal Biologics Revenue Market Share by Countries (2014-2019)
Figure South America Retinal Biologics Revenue Market Share by Countries in 2018
Figure Brazil Retinal Biologics Revenue and Growth Rate (2014-2019)
Figure Argentina Retinal Biologics Revenue and Growth Rate (2014-2019)
Figure Colombia Retinal Biologics Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Retinal Biologics Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Retinal Biologics Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Retinal Biologics Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Retinal Biologics Revenue Market Share by Countries in 2018
Figure Saudi Arabia Retinal Biologics Revenue and Growth Rate (2014-2019)
Figure UAE Retinal Biologics Revenue and Growth Rate (2014-2019)
Figure Egypt Retinal Biologics Revenue and Growth Rate (2014-2019)
Figure Nigeria Retinal Biologics Revenue and Growth Rate (2014-2019)
Figure South Africa Retinal Biologics Revenue and Growth Rate (2014-2019)
Table Global Retinal Biologics Revenue (Million USD) by Type (2014-2019)
Table Global Retinal Biologics Revenue Share by Type (2014-2019)
Figure Global Retinal Biologics Revenue Share by Type (2014-2019)
Figure Global Retinal Biologics Revenue Share by Type in 2019
Table Global Retinal Biologics Revenue Forecast by Type (2019-2024)
Figure Global Retinal Biologics Market Share Forecast by Type (2019-2024)
Figure Global Macular Degeneration Revenue Growth Rate (2014-2019)
Figure Global Diabetic Retinopathy Revenue Growth Rate (2014-2019)
Figure Global Diabetic Macular Edema Revenue Growth Rate (2014-2019)
Figure Global Uveitis Revenue Growth Rate (2014-2019)
Figure Global Others Revenue Growth Rate (2014-2019)
Table Global Retinal Biologics Revenue by Application (2014-2019)
Table Global Retinal Biologics Revenue Share by Application (2014-2019)
Figure Global Retinal Biologics Revenue Share by Application (2014-2019)
Figure Global Retinal Biologics Revenue Share by Application in 2019
Table Global Retinal Biologics Revenue Forecast by Application (2019-2024)
Figure Global Retinal Biologics Market Share Forecast by Application (2019-2024)
Figure Global Hospitals Revenue Growth Rate (2014-2019)
Figure Global Clinics Revenue Growth Rate (2014-2019)
Figure Global Others Revenue Growth Rate (2014-2019)
Figure Global Retinal Biologics Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Retinal Biologics Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Retinal Biologics Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Retinal Biologics Revenue Market Forecast (2019-2024)
Figure Europe Retinal Biologics Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Retinal Biologics Revenue Market Forecast (2019-2024)
Figure South America Retinal Biologics Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Retinal Biologics Revenue Market Forecast (2019-2024)


【掲載企業】

Spark Therapeutics, Inc、F. Hoffmann-La Roche Ltd、Regeneron Pharmaceuticals, Inc、AbbVie Inc、Johnson & Johnson Services, Inc、Amgen Inc、

【免責事項】
https://www.globalresearch.jp/disclaimer
★リサーチレポート[ 網膜生物製剤の世界市場2019(Global Retinal Biologics Market 2019 by Company, Regions, Type and Application, Forecast to 2024)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • 拡張プラグバルブの世界市場2019
  • サービスレベル管理ソフトウェアの世界市場2019
  • 契約開発および製造組織（CDMO）の世界市場2019
  • リサイクルガラスの世界市場2019
  • IO-Linkマスタの世界市場2019
  • 脳モニタリングシステムの世界市場2019
  • 統合LC-MSソリューションの世界市場2019
  • 福利管理ソリューションの世界市場2019
  • 色素沈着低下障害治療の世界市場2019
  • アプリケーションセキュリティテストツールの世界市場2019
  • 医薬品グレード人造樟脳の世界市場2019
  • ジベレリンの世界市場2019
  • 自動車用シャークフィンアンテナの世界市場2019
  • オンライン校正ソフトウェアの世界市場2019
  • アニデュラファンギンの世界市場2019